
XERS
Healthcare · Drug Manufacturers - Specialty & Generic · $3.04B market cap
$16.66+0.01 (+0.1%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +27.3% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 3 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 5, 2026 | Before the open | 0.02 | 0.06 | +200.0% |
| Aug 6, 2026 | Before the open | 0.02 | -0.01 | -150.0% |
| May 7, 2026 | Before the open | -0.01 | 0.01 | +200.0% |
| Mar 2, 2026 | Time not confirmed | 0.02 | 0.06 | +261.4% |
| Nov 6, 2025 | Before the open | 0.01 | 0.00 | -65.0% |
| Aug 7, 2025 | Before the open | -0.03 | -0.01 | +66.7% |
| May 8, 2025 | Before the open | -0.04 | -0.06 | -50.0% |
| Mar 4, 2025 | Before the open | -0.02 | -0.03 | -50.0% |
| Nov 8, 2024 | Before the open | -0.08 | -0.06 | +25.0% |
| Aug 8, 2024 | Before the open | -0.09 | -0.10 | -11.1% |
| May 9, 2024 | Before the open | -0.11 | -0.14 | -27.3% |
| Mar 6, 2024 | Before the open | -0.10 | -0.10 | 0.0% |
| Nov 9, 2023 | Before the open | -0.10 | -0.09 |
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary…
| +10.0% |
| Aug 8, 2023 | Before the open | -0.11 | -0.14 | -27.3% |
| May 9, 2023 | Before the open | -0.15 | -0.12 | +20.0% |
| Mar 8, 2023 | Before the open | -0.16 | -0.10 | +37.5% |
| Nov 9, 2022 | Before the open | -0.15 | -0.16 | -6.7% |
| Aug 10, 2022 | Before the open | -0.22 | -0.19 | +13.6% |
| May 11, 2022 | Before the open | -0.24 | -0.25 | -4.2% |
| Mar 10, 2022 | Before the open | -0.24 | -0.42 | -75.0% |
| Nov 10, 2021 | Before the open | -0.37 | -0.39 | -5.4% |
| Aug 5, 2021 | Before the open | -0.30 | -0.41 | -36.7% |
| May 13, 2021 | Before the open | -0.34 | -0.30 | +11.8% |
| Mar 9, 2021 | Before the open | -0.38 | -0.41 | -7.9% |
| Nov 9, 2020 | Before the open | -0.52 | -0.35 | +32.7% |
| Aug 10, 2020 | Before the open | -0.73 | -0.63 | +13.7% |
| May 7, 2020 | Before the open | -0.89 | -0.89 | 0.0% |
| Mar 11, 2020 | Before the open | -1.13 | -1.23 | -8.8% |
| Nov 7, 2019 | Before the open | -1.23 | -1.22 | +0.8% |
| Aug 6, 2019 | After the close | -0.94 | -1.28 | -36.2% |
| May 9, 2019 | After the close | -0.76 | -1.07 | -40.8% |
| Mar 6, 2019 | After the close | -0.93 | -0.98 | -5.4% |
| Nov 7, 2018 | Before the open | -0.78 | -0.71 | +9.0% |
| Aug 13, 2018 | Before the open | -0.88 | -3.07 | -248.9% |
| Jun 21, 2018 | After the close | 0.00 | -4.69 | — |
| Feb 3, 2018 | Time not confirmed | — | -1.29 | — |